Related Experiment Video
Updated: May 5, 2026

10:58
Combinatorial Synthesis of and High-throughput Protein Release from Polymer Film and Nanoparticle Libraries
Published on: September 6, 2012
9.9K
Controlled release of polypeptides and other macromolecules
1Whitaker College of Health Science, Technology, and Management, USA.
Pharmaceutical Research
|November 27, 2013
Summary
Polymeric matrices offer controlled drug release via diffusion, erosion, or magnetic fields. These methods enable sustained polypeptide delivery for extended periods, enhancing therapeutic applications.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Polymer Chemistry
Background:
- Controlled release of macromolecular drugs, such as polypeptides, is crucial for effective therapy.
- Polymeric matrices are widely investigated for their potential in drug delivery applications.
- Challenges include achieving sustained release and precise control over drug elution.
Purpose of the Study:
- To review the mechanisms of controlled release of polypeptides from polymeric matrices.
- To highlight the advantages and applications of different release strategies.
- To discuss the potential of these systems for long-term drug delivery.
Main Methods:
- Review of literature on polymeric matrices for controlled drug release.
- Analysis of release mechanisms: diffusion, bioerosion, and magnetic field application.
- Examination of materials like ethylene-vinyl acetate copolymer for diffusion-controlled systems.
Main Results:
- Diffusion through polymeric matrices, particularly ethylene-vinyl acetate copolymer, allows for tunable pore structures and controlled release kinetics.
- Bioerodible polymers offer the advantage of not requiring retrieval after drug delivery.
- Magnetic fields provide a method for on-demand modulation of polypeptide release rates.
Conclusions:
- Polymeric matrices offer versatile platforms for the controlled release of polypeptides.
- Diffusion, bioerosion, and magnetic actuation represent key mechanisms for achieving desired release profiles.
- These advanced drug delivery systems hold significant promise for long-term and responsive therapeutic applications.
More Related Videos
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
184
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
184
Overview of Secretory Vesicles
8.9K
Secretory vesicles, also known as dense core vesicles (DCVs), are membrane-bound vesicles that transport secretory proteins, such as hormones or neurotransmitters. Regulated secretory vesicles transport proteins from the trans-Golgi network to the exterior of the cell. Proteins present in regulated secretory vesicles are required to be rapidly exocytosed in large amounts upon a specific stimulus.
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
8.9K
Modified-Release Drug Delivery Systems: Rate-Programmed II
139
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
139
Exocytosis
62.4K
Exocytosis is used to release material from cells. Like other bulk transport mechanisms, exocytosis requires energy.
62.4K
Exocytosis
8.1K
Exocytosis is a process that releases molecules outside the cell. Like other bulk transport mechanisms, exocytosis requires energy.
Exocytosis is the opposite of endocytosis, which brings molecules inside the cell. Sometimes, the released materials are signaling molecules. For example, neurons typically use exocytosis to release neurotransmitters. Cells also use exocytosis to insert proteins such as ion channels into their cell membranes, secrete proteins for use in the extracellular matrix, or...
Exocytosis is the opposite of endocytosis, which brings molecules inside the cell. Sometimes, the released materials are signaling molecules. For example, neurons typically use exocytosis to release neurotransmitters. Cells also use exocytosis to insert proteins such as ion channels into their cell membranes, secrete proteins for use in the extracellular matrix, or...
8.1K
Post-translational Translocation of Proteins to the RER
5.7K
A sizable fraction of proteins destined for ER are first synthesized in the cell cytosol and then transported across the ER membrane–a process called post-translational translocation. Similar to cotranslationally translocated proteins, these proteins also use the Sec translocon complex to enter the ER lumen.
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
Targeting proteins to the ER
Hsp40 and Hsp70 chaperone molecules bind the translated proteins in the cytosol to prevent their folding. The chaperone binding helps to keep the signal...
5.7K

